Woodline Partners’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Woodline Partners’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-50,000	Closed	-$522K	–	806
2023 Q1	$522K	Hold	50,000	–	–	0.01%	524
2022 Q4	$512K	Hold	50,000	–	–	0.01%	603
2022 Q3	$501K	Hold	50,000	–	–	0.01%	591
2022 Q2	$499K	Hold	50,000	–	–	0.01%	568
2022 Q1	$494K	Buy	+50,000	New	+$493K	0.01%	517

Other funds holding BIOS

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Quarry LP New York $1.2B AUM 47.63% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Woodline Partners's BIOS Position: Q2 2023 in Review

Woodline Partners sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q2 2023, closing a stake of 50,000 shares — an estimated $522K sold.

Woodline Partners first reported a position in BIOS in Q1 2022 and held it in 5 quarters. The position peaked at $522K in Q1 2023. 32 funds tracked by Wall St. Rank hold BIOS as of Q2 2023.

Woodline Partners reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Woodline Partners sold 50,000 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q2 2023, an estimated $522K.
Woodline Partners first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 5 quarters.
Woodline Partners's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $522K in Q1 2023.
32 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q2 2023.

Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.